Liraglutide
i-LAB
Novo Nordisk · Phase 3 · Status n/r · Enrollment 20
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Liraglutide 3.0 mg | n/r | n/r | n/r | n/r |
Not shown
- Liraglutide 3.0 mg: endpoint not reported